Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer
Authors:
- Yasemin ŞanliYŞYasemin Şanli
- Cemil B. KülleCKCemil B. Külle
- Hasan KaranlikHKHasan Karanlik
- Berkay KiliçBKBerkay Kiliç
- Serkan KuyumcuSKSerkan Kuyumcu
- Semen ÖnderSÖSemen Önder
- Vahit ÖzmenVÖVahit Özmen
- 1 August 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 38 (8) , 694-700
Abstract
The aim of this study was to determine the correlation between the primary tumor (PT) maximum standardized uptake value (SUVmax) and breast cancer prognostic factors, overall survival, and relapse-free survival on the basis of histopathological and molecular characteristics. In this retrospective study, 436 female patients with breast cancer were evaluated following a pretreatment 18F-FDG PET/CT scan. The PT SUVmax and histopathological/molecular characteristics were determined from primary tumor tissues and analyzed using the Mann–Whitney U and Kruskal–Wallis tests. The median SUVmax of 436 PT was 10.1 (1.7–72). The PT SUVmax values were higher in ER− versus ER+ (P=0.001), PR− versus PR+ (P=0.001), Her2+ versus Her2− (P=0.01), Ki-67% of at least 20 versus Ki-67% of less than 20 (P<0.001), histological grade 3 versus grade 1–2 (P<0.001), nuclear pleomorphism score 3 versus score 1–2 (P<0.001), and mitotic score 3 versus score 1–2 patients (P<0.001). The lowest SUVmax levels were observed in the LumA group and the highest SUVmax levels were observed in the Her2 group (P<0.001). LumA patients with PR values greater than 20% had lower PT SUVmax values than the patients with PR values of 20% or less (P=0.023). The PT SUVmax was higher in patients with recurrence (P=0.03) and died related to disease (P<0.001) independent of time. The PT SUVmax showed a significant correlation with most of the prognostic factors and histopathological subtypes as a noninvasive tool. It is also usable in the prediction of tumor-related deaths or relapse independent of time. Our results could guide future studies to provide new histopathologic subtype definitions on the basis of new PR criteria.Keywords
This publication has 29 references indexed in Scilit:
- Association between 18F-FDG uptake and molecular subtype of breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2− Breast CancerJournal of Nuclear Medicine, 2015
- Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burdenBreast Cancer Research, 2014
- Addressing overtreatment in breast cancerCancer, 2013
- Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant TherapyJNCI: Journal of the National Cancer Institute, 2008
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000